|
|
Session 6: New & Emerging Biomarkers & Drug Targets
|
|
Session Chair: Dr. Glenn McConkey, Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, UK
Co-Chair: Dr. Armando Bartolazzi , St. Andrea University Hospital, Rome, Italy; Cellular and Molecular Tumor Pathology Laboratory, Cancer Center Karolinska, Karolinska Hospital, Stockholm, Sweden |
|
|
Title: Biomarkers and Drug Development: Practical US Experience
Dr. Gregory M. Hockel, Vice President, Regulatory Affairs
PharmaNet, LLC, USA
|
|
Title: IXPC gene silencing as an important biomarker in lung and bladder cancer progression
Dr. Gan Wang, Associate Professor, Institute of Environmental Health Sciences, Wayne State University, Detroit, USA
|
|
Title: Targeting Parasitic Diseases and Design of Novel Inhibitors as Antimalarial Agents
Dr. Glenn McConkey, Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, UK
|
|
Title: Novel Mictotubule-drugs as Anti-cancer, Non-toxic, Orally Available Agents
Dr. Harish C. Joshi, Director, Laboratory of Drug Discovery, Design & Research, Department of Cell Biology Emory University School of Medicine, Atlanta, USA |
|
Title: Development of Functional Magnetic Nanobeads for Drug Target Screening
Dr. Satoshi Sakamoto, Assistant Professor, Department of Biological Information, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Japan
|
|
Title: Galectin-3 thyrotest in the preoperative characterization of thyroid nodules
Dr. Armando Bartolazzi, St. Andrea University Hospital, Rome, Italy; Cellular and Molecular Tumor Pathology Laboratory, Cancer Center Karolinska, Karolinska Hospital, Stockholm, Sweden
|
|
Title: G-quadruplex Structures of Nucleic Acids as Potential Targets for Drug Design
Dr. Anh Tuan Phan, Division of Physics & Applied Physics, School of Physical & Mathematical Sciences, Nanyang Technological University, Singapore
|
|
Title: PI3K-AKT Network as a Therapeutic Target For Human Diseases
Dr. Masayuki Noguchi, Professor, Division of Cancer, BiologyInstitute for Genetic Medicine, Hokkaido University, Japan
|
|
Title: The Replication Combing Assay: A sensitive and quantitative assay for monitoring the efficacy of drugs on DNA replication
Dr. Aaron Bensimon, Founder and CEO of Genomic Vision, Paris, France |
|
